C5a and mammary cancers.

Mammary cancers are among the most common neoplastic conditions in dogs, and there is evidence that inflammation plays a role in the development of some cancer types in dogs. The compiement system is a major participant in the inflammatory process and the compiement activation component, C5a, is a p...

Full description

Bibliographic Details
Main Author: Mohd Noor, Mohd Hezmee
Format: Conference or Workshop Item
Language:English
English
Published: 2013
Online Access:http://psasir.upm.edu.my/id/eprint/26829/
http://psasir.upm.edu.my/id/eprint/26829/1/ID%2026829.pdf
_version_ 1848845683875905536
author Mohd Noor, Mohd Hezmee
author_facet Mohd Noor, Mohd Hezmee
author_sort Mohd Noor, Mohd Hezmee
building UPM Institutional Repository
collection Online Access
description Mammary cancers are among the most common neoplastic conditions in dogs, and there is evidence that inflammation plays a role in the development of some cancer types in dogs. The compiement system is a major participant in the inflammatory process and the compiement activation component, C5a, is a potent infiammatory peptide. Complement C5a is a pro-inflammatory polypeptide produced during activation of the complement cascade in response to foreign antigens or tissue damage secondary to physical or chemical injury. C5a, via activation of it specific receptor (the C5a receptor) is a major inflammatory mediator contributing to a number of diseases, such osteoarthritis, sepsis and kidney disease. The inflammatory process is integral to many forms of neoplasia and anti-inflammatory therapy is frequently used as an adjunctive treatment for various forms of neoplasia. There is increasing evidence that modulation of complement mediators may be useful to treat a range of diseases where inflammation piays some role This paper will describe some of links between C5 a and mammary neopiasia in the dog, potentially leading to novel therapeutic approaches.
first_indexed 2025-11-15T08:50:43Z
format Conference or Workshop Item
id upm-26829
institution Universiti Putra Malaysia
institution_category Local University
language English
English
last_indexed 2025-11-15T08:50:43Z
publishDate 2013
recordtype eprints
repository_type Digital Repository
spelling upm-268292014-06-13T02:39:57Z http://psasir.upm.edu.my/id/eprint/26829/ C5a and mammary cancers. Mohd Noor, Mohd Hezmee Mammary cancers are among the most common neoplastic conditions in dogs, and there is evidence that inflammation plays a role in the development of some cancer types in dogs. The compiement system is a major participant in the inflammatory process and the compiement activation component, C5a, is a potent infiammatory peptide. Complement C5a is a pro-inflammatory polypeptide produced during activation of the complement cascade in response to foreign antigens or tissue damage secondary to physical or chemical injury. C5a, via activation of it specific receptor (the C5a receptor) is a major inflammatory mediator contributing to a number of diseases, such osteoarthritis, sepsis and kidney disease. The inflammatory process is integral to many forms of neoplasia and anti-inflammatory therapy is frequently used as an adjunctive treatment for various forms of neoplasia. There is increasing evidence that modulation of complement mediators may be useful to treat a range of diseases where inflammation piays some role This paper will describe some of links between C5 a and mammary neopiasia in the dog, potentially leading to novel therapeutic approaches. 2013 Conference or Workshop Item NonPeerReviewed application/pdf en http://psasir.upm.edu.my/id/eprint/26829/1/ID%2026829.pdf Mohd Noor, Mohd Hezmee (2013) C5a and mammary cancers. In: 2013 Australian Veterinary Association (AVA) Annual Conference, 26-31 May 2013, Queensland, Australia. . (Unpublished) English
spellingShingle Mohd Noor, Mohd Hezmee
C5a and mammary cancers.
title C5a and mammary cancers.
title_full C5a and mammary cancers.
title_fullStr C5a and mammary cancers.
title_full_unstemmed C5a and mammary cancers.
title_short C5a and mammary cancers.
title_sort c5a and mammary cancers.
url http://psasir.upm.edu.my/id/eprint/26829/
http://psasir.upm.edu.my/id/eprint/26829/1/ID%2026829.pdf